نتایج جستجو برای: adenoviral vector

تعداد نتایج: 201214  

2011
Christina Theresa Rauschhuber Anja Ehrhardt Christina Rauschhuber

....................................................................................................................... 1 Introduction ............................................................................................................1 1.1 Adenoviral Vectors ...................................................................................................2 1.1.1 Adenovirus...

2012
Xin-Ran Liu Ying Cai Xin Cao Rui-Cheng Wei Hui-Ling Li Xiu-Mei Zhou Kang-Jian Zhang Shuai Wu Qi-Jun Qian Biao Cheng Kun Huang Xin-Yuan Liu

Cancer Targeting Gene-Viro-Therapy (CTGVT) is a promising cancer therapeutical strategy that strengthens the anti-tumour effect of oncolytic virus by expressing inserted foreign anti-tumour genes. In this work, we constructed a novel adenoviral vector controlled by the tumour-specific survivin promoter on the basis of the ZD55 vector, which is an E1B55KD gene deleted vector we previously constr...

Amir Babak Sioofy Khojine, Mohammad Saeid Hejazi,

Knowing that adenoviral vectors could initiate innate immunity, the ability of E1-deleted recombinant adenovirus (Ad-E1Δ) in induction of B7.1 and IL-2 molecules was studied. Methods: The expression of green fluorescent protein in C1498 cells following transfection of these cells with adenovirus green fluorescent protein vector confirmed the ability of adenovirus vectors in infecting the cells ...

Journal: :Cancer research 2001
X Y Peng J H Won T Rutherford T Fujii D Zelterman G Pizzorno E Sapi J Leavitt B Kacinski R Crystal P Schwartz A Deisseroth

A 2.4-kb truncated L-plastin promoter was inserted either 5' to the LacZ gene (Ad-Lp-LacZ) or 5' to the cytosine deaminase (CD) gene (Ad-Lp-CD) in a replication-incompetent adenoviral vector backbone. Infectivity and cytotoxicity experiments with the LacZ and CD vectors suggested that the L-plastin promoter-driven transcriptional units were expressed at much higher levels in explants of ovarian...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2008
Anton P McCaffrey Paul Fawcett Hiroyuki Nakai Ramona L McCaffrey Anja Ehrhardt Thu-Thao T Pham Kusum Pandey Hui Xu Sally Feuss Theresa A Storm Mark A Kay

Understanding host responses to viral gene therapy vectors is necessary for the development of safe and efficacious in vivo gene transfer agents. We describe the use of high-density spotted complementary DNA microarrays in monitoring the in vivo host transcriptional responses in mouse liver upon administration of either a "first-generation"adenoviral (Ad) vector, a helper-dependent "gutless" ad...

Journal: :Genetic Vaccines and Therapy 2008
Daniela Damjanovic Xizhong Zhang Jingyu Mu Maria Fe Medina Zhou Xing

It is believed that respiratory mucosal immunization triggers more effective immune protection than parenteral immunization against respiratory infection caused by viruses and intracellular bacteria. Such understanding has led to the successful implementation of intranasal immunization in humans with a live cold-adapted flu virus vaccine. Furthermore there has been an interest in developing eff...

Journal: :Human gene therapy 1999
C Gao R Jokerst P Gondipalli S R Cai S Kennedy K P Ponder

Retroviral vectors can result in therapeutic and stable levels of expression of proteins from the liver. However, most retroviral vectors transduce only dividing cells, and hepatocytes are normally quiescent. The goal of this study was to determine if an adenoviral vector could transiently express hepatocyte growth factor (HGF) in order to induce hepatocyte replication and facilitate retroviral...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2000
B Hutchins N Sajjadi S Seaver A Shepherd S R Bauer S Simek K Carson E Aguilar-Cordova

2014
MASAMI WATANABE MASAKIYO SAKAGUCHI RIE KINOSHITA HARUKI KAKU YUICHI ARIYOSHI HIDEO UEKI RYUTA TANIMOTO SHIN EBARA KAZUHIKO OCHIAI JUNICHIRO FUTAMI SHUN-AI LI PENG HUANG YASUTOMO NASU NAM-HO HUH HIROMI KUMON

Gene expression systems with various promoters, including the cytomegalovirus (CMV) promoter, have been developed to increase the gene expression in a variety of normal and cancer cells. In particular, in the clinical trials of cancer gene therapy, a more efficient and robust gene expression system is required to achieve sufficient therapeutic outcomes. By inserting the triple translational enh...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید